MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Karim, Zubair A ^a   Vemana, Hari Priya ^a   Khasawneh, Fadi T ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAIIBBETA3 INTEGRIN; BINDING PROTEIN; CALCIUM ION; CELL PROTEIN; I KAPPA B KINASE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; PHOSPHATIDYLSERINE; PROTEIN BCL 10; PROTEIN CARMA; PROTEIN MALT1; SNARE PROTEIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 BINDING PROTEIN 2; UNCLASSIFIED DRUG; CASPASE; MALT1 PROTEIN, HUMAN; MALT1 PROTEIN, MOUSE; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CALCIUM CELL LEVEL; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HEMOSTASIS; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; UBIQUITINATION; ANIMAL; FEMALE; MALE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CASPASES; FEMALE; HUMANS; I-KAPPA B KINASE; MALE; MICE; NEOPLASM PROTEINS; NF-KAPPA B; PLATELET ACTIVATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84929093894     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119363     Document Type: Article

References (47)

1. Lee DH, Goldberg AL (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends in cell biology 8: 397-403. PMID: 9789328
2. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proceedings of the National Academy of Sciences of the United States of America 96: 10403-10408. PMID: 10468620
3. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785. PMID: 8087845
4. Schwartz AL, Ciechanover A (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annual review of medicine 50: 57-74. PMID: 10073263
5. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annual review of biochemistry 65: 801-847. PMID: 8811196
6. Nayak MK, Kulkarni PP, Dash D (2013) Regulatory role of proteasome in determination of platelet life span. The Journal of biological chemistry 288: 6826-6834. doi: 10.1074/jbc.M112.403154 PMID: 23329846
7. Nayak MK, Singh SK, Roy A, Prakash V, Kumar A, et al. (2011) Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen. Thrombosis and haemostasis 106: 624-635. doi: 10.1160/TH11-03-0178 PMID: 21866300
8. Shi DS, Smith MC, Campbell RA, Zimmerman PW, Franks ZB, et al. (2014) Proteasome function is required for platelet production. The Journal of clinical investigation 124: 3757-3766. doi: 10.1172/JCI75247 PMID: 25061876
9. Conner EM, Brand S, Davis JM, Laroux FS, Palombella VJ, et al. (1997) Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. The Journal of pharmacology and experimental therapeutics 282: 1615-1622. PMID: 9316879
10. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, et al. (1995) The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2: 493-506. PMID: 7538441
11. Xia L, Pan J, Yao L, McEver RP (1998) A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells. Blood 91: 1625-1632. PMID: 9473228
12. Ostrowska JK, Wojtukiewicz MZ, Chabielska E, Buczko W, Ostrowska H (2004) Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats. Thrombosis and haemostasis 92: 171-177. PMID: 15213858
13. Karim ZA, Zhang J, Banerjee M, Chicka MC, Al Hawas R, et al. (2013) IkappaB kinase phosphorylation of SNAP-23 controls platelet secretion. Blood 121: 4567-4574. doi: 10.1182/blood-2012-11-470468 PMID: 23613522
14. Nair-Gupta P, Baccarini A, Tung N, Seyffer F, Florey O, et al. (2014) TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation. Cell 158: 506-521. doi: 10.1016/j.cell.2014.04.054 PMID: 25083866
15. Wei S, Wang H, Zhang G, Lu Y, An X, et al. (2013) Platelet IkappaB kinase-beta deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibalpha shedding. Arteriosclerosis, thrombosis, and vascular biology 33: 241-248. doi: 10.1161/ATVBAHA.112.300781 PMID: 23241410
16. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes & development 18: 2195-2224.
17. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nature reviews Immunology 2: 725-734. PMID: 12360211
18. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nature reviews Molecular cell biology 8: 49-62. PMID: 17183360
19. Scheidereit C (2006) IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25: 6685-6705. PMID: 17072322
20. Rosebeck S, Lucas PC, McAllister-Lucas LM (2011) Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment. Future oncology 7: 613-617. doi: 10.2217/fon.11.35 PMID: 21568677
21. Staal J, Bekaert T, Beyaert R (2011) Regulation of NF-kappaB signaling by caspases and MALT1 paracaspase. Cell research 21: 40-54. doi: 10.1038/cr.2010.168 PMID: 21119681
22. Thome M, Charton JE, Pelzer C, Hailfinger S (2010) Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harbor perspectives in biology 2: a003004. doi: 10.1101/cshperspect.a003004 PMID: 20685844
23. Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, et al. (2007) Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. The EMBO journal 26: 4634-4645. PMID: 17948050
24. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Molecular cell 14: 289-301. PMID: 15125833
25. Wu CJ, Ashwell JD (2008) NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proceedings of the National Academy of Sciences of the United States of America 105: 3023-3028. doi: 10.1073/pnas.0712313105 PMID: 18287044
26. Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Science's STKE: signal transduction knowledge environment 2006: re13. PMID: 17047224
27. Lin OA, Karim ZA, Vemana HP, Espinosa EV, Khasawneh FT (2014) The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function. PloS one 9: e87026. doi: 10.1371/journal.pone.0087026 PMID: 24466319
28. Osdoit S, Rosa JP (2001) Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation. The Journal of biological chemistry 276: 6703-6710. PMID: 11084040
29. Pelzer C, Cabalzar K, Wolf A, Gonzalez M, Lenz G, et al. (2013) The protease activity of the paracaspase MALT1 is controlled by monoubiquitination. Nature immunology 14: 337-345. doi: 10.1038/ni.2540 PMID: 23416615
30. Jackson SP (2011) Arterial thrombosis - insidious, unpredictable and deadly. Nature medicine 17: 1423-1436. doi: 10.1038/nm.2515 PMID: 22064432
31. Haling JR, Monkley SJ, Critchley DR, Petrich BG (2011) Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood 117: 1719-1722. doi: 10.1182/blood-2010-09-305433 PMID: 20971947
32. Stull JT, Tansey MG, Tang DC, Word RA, Kamm KE (1993) Phosphorylation of myosin light chain kinase: a cellular mechanism for Ca2+ desensitization. Molecular and cellular biochemistry 127-128: 229-237.
33. Suzuki-Inoue K, Hughes CE, Inoue O, Kaneko M, Cuyun-Lira O, et al. (2007) Involvement of Src kinases and PLCgamma2 in clot retraction. Thrombosis research 120: 251-258. PMID: 17055557
34. Leon C, Eckly A, Hechler B, Aleil B, Freund M, et al. (2007) Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 110: 3183-3191. PMID: 17664350
35. Munnix IC, Kuijpers MJ, Auger J, Thomassen CM, Panizzi P, et al. (2007) Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arteriosclerosis, thrombosis, and vascular biology 27: 2484-2490. PMID: 17761939
36. Lang F, Munzer P, Gawaz M, Borst O (2013) Regulation of STIM1/Orai1-dependent Ca2+ signalling in platelets. Thrombosis and haemostasis 110: 925-930. doi: 10.1160/TH13-02-0176 PMID: 23846758
37. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Molecular cell 22: 245-257. PMID: 16603398
38. Li H, Kobayashi M, Blonska M, You Y, Lin X (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. The Journal of biological chemistry 281: 13636-13643. PMID: 16543241
39. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nature cell biology 8: 398-406. PMID: 16547522
40. Dangelmaier CA, Quinter PG, Jin J, Tsygankov AY, Kunapuli SP, et al. (2005) Rapid ubiquitination of Syk following GPVI activation in platelets. Blood 105: 3918-3924. PMID: 15701717
41. Daniel JL, Dangelmaier CA, Mada S, Buitrago L, Jin J, et al. (2010) Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation. The Journal of biological chemistry 285: 17282-17291. doi: 10.1074/jbc.M109.080200 PMID: 20400514
42. Shuto T, Xu H, Wang B, Han J, Kai H, et al. (2001) Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 98: 8774-8779. PMID: 11438700
43. Gross O, Gewies A, Finger K, Schafer M, Sparwasser T, et al. (2006) Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442: 651-656. PMID: 16862125
44. Klemm S, Zimmermann S, Peschel C, Mak TW, Ruland J (2007) Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production. Proceedings of the National Academy of Sciences of the United States of America 104: 134-138. PMID: 17095601
45. McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, et al. (2007) CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proceedings of the National Academy of Sciences of the United States of America 104: 139-144. PMID: 17101977
46. Wang D, You Y, Lin PC, Xue L, Morris SW, et al. (2007) Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors. Proceedings of the National Academy of Sciences of the United States of America 104: 145-150. PMID: 17179215
47. Grabiner BC, Blonska M, Lin PC, You Y, Wang D, et al. (2007) CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes & development 21: 984-996.